Judge slashes $8 billion Risperdal award against Johnson & Johnson to $6.8 million [Reuters (UK)]
Johnson & Johnson (JNJ)
Last johnson & johnson earnings: 4/14 06:31 am
Check Earnings Report
US:NYSE Investor Relations:
jnj.com
Company Research
Source: Reuters
Judge slashes $8 billion Risperdal award against Johnson & Johnson to $6.8 million - Reuters 1 Min Read (Reuters) - A Pennsylvania judge on Friday slashed to $6.8 million from $8 billion a punitive damages award against Johnson & Johnson for allegedly failing to warn men that they could grow breasts by using its antipsychotic drug Risperdal. The decision by Judge Kenneth Powell of the Philadelphia Court of Common Pleas to reduce punitive damages for the plaintiff Nicholas Murray followed a jury’s imposition of the original award last Oct. 8. No reason was immediately given for the reduction, which was disclosed in court records. Murray, like other male plaintiffs in mass tort litigation over Risperdal, claimed that he developed breasts after being prescribed the medicine when he was a boy. He was 26 when the jury made the $8 billion award. Reporting by Jonathan Stempel in New York, Editing by Rosalba O'Brien All quotes delayed a minimum of 15 minutes. See here for a complete list o
Show less
Read more
Impact Snapshot
Event Time:
JNJ
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
JNJ alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
JNJ alerts
High impacting Johnson & Johnson news events
Weekly update
A roundup of the hottest topics
JNJ
News
- David Egilman, Doctor Who Took On Drug Companies, Dies at 71 [The New York Times]The New York Times
- WHO warns of falsified cough syrup ingredients seized in Pakistan [Reuters]Reuters
- WHO warns of falsified cough syrup ingredients seized in Pakistan [Yahoo! Finance]Yahoo! Finance
- Global Retinoid Market Poised for Growth, Expected to Reach US$ 3.05 Billion by 2034 at a moderate CAGR of 6.5% | Future Market Insights [Yahoo! Finance]Yahoo! Finance
- Should You Buy Johnson & Johnson (JNJ) Ahead of Earnings? [Yahoo! Finance]Yahoo! Finance
JNJ
Earnings
- 1/23/24 - Beat
JNJ
Sec Filings
- 3/27/24 - Form PX14A6G
- 3/13/24 - Form 4
- 3/13/24 - Form 144
- JNJ's page on the SEC website